Looking for swim classes? Edibles? Try these new North Jersey sites
The Record, NorthJersey.com, the Daily Record and the New Jersey Herald want to keep you up to date on all the newest shops, restaurants and service providers moving into your towns. Below is a roundup of businesses that recently opened or are coming soon.
Are you opening a business in North Jersey? Get the word out to your neighbors as soon as possible. Send us your information and photos and we will try to add them to our next new-business roundup.
We're also interested in reporting business closings. Have a tip? Contact Business Reporter Daniel Munoz at munozd@northjersey.com, or 201-270-9870.
Story continues below photo gallery
Cannabis dispensary offering a variety of products, including flower, pre-rolls, vaporizers, edibles, concentrates and tinctures.
WHERE: 523 Washington Ave., Belleville
WHEN: Grand opening was March 22. Hours are 10 a.m. to 8 p.m. seven days a week.
FOR MORE INFORMATION: Visit https://www.lavidagardens.com/
Everyday essentials for members include groceries, household goods, home décor, pet supplies, toys and consumer electronics.
WHERE: 352 Route 10, Whippany
WHEN: Opening was March 21. Hours are 9 a.m. to 7 p.m. Monday through Saturday and 10 a.m. to 6 p.m. Sunday.
FOR MORE INFORMATION: Visit https://www.bjs.com/content?template=B&espot_main=minisite_whippany
Offering small-size swim lessons and water safety classes for children.
WHERE: 1595 Route 23 South, Unit 1, Wayne
WHEN: Grand opening was April 6. Hours are 10 a.m. to 7 p.m. Monday, Tuesday and Thursday; 10 a.m. to 4 p.m. Wednesday and Friday; 9 a.m. to 2 p.m. Saturday; and 9 a.m. to 12 p.m. Sunday.
FOR MORE INFORMATION: Visit https://goldfishswimschool.com/wayne/
Daniel Munoz covers business, consumer affairs, labor and the economy for NorthJersey.com and The Record.
Email: munozd@northjersey.com; Twitter:@danielmunoz100 and Facebook
This article originally appeared on NorthJersey.com: Looking for swim classes? Edible? Try these new NJ sites
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
12 hours ago
- Associated Press
Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ('Neural' or the 'Company'), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ('CWE'), operating as one of the Germany's leading CBD retailers, are pleased to provide an update on expansion efforts in Germany. A subsidiary of CWE has signed a franchise agreement to open the first in the City of Bonn-the former capital of The Federal Republic of Germany and home to over 320,000 residents. This marks 's fifth franchise agreement and the second store in the state of North Rhine-Westphalia. is also proud to announce its participation in Mary Jane Berlin 2025, Europe's premier cannabis trade show and festival, taking place June 19-22, 2025 at Messe Berlin. As part of the event's vibrant exhibition floor, will showcase its latest product innovations, including premium CBD oils, sustainable hemp-based wellness items, and exclusive new lifestyle offerings. Visitors can find at Booth #G19/G20, where they will be invited to explore, sample, and connect with the team behind one of the most trusted names in the hemp space. Alex Cerveny, COO of commented: 'We are excited to bring the experience to Bonn-a city with deep roots and a progressive spirit. This new franchise marks an important step in our mission to make high-quality CBD products accessible to customers across Germany. We look forward to serving the Bonn community with the same passion, integrity, and innovation that defines the brand.' 'We are also thrilled to be part of Mary Jane Berlin again this year and invite our friends, partners, and associates to come meet our team.' Mr. Cerveny added: 'This event is not just a trade show-it's a celebration of cannabis culture, innovation, and progress. We look forward to engaging with industry partners and consumers to showcase our carefully curated portfolio of CBD products, as we continue paving the way for opening more franchise locations.' Now in its ninth year, Mary Jane Berlin is expected to welcome over 60,000 visitors and more than 500 exhibitors from around the world. Programming includes expert panels, live music, food trucks, and a dedicated B2B business day. About Neural Therapeutics Neural Therapeutics is a leader in ethnobotanical drug discovery, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy. On May 26, 2025, Neural entered into a Strategic Investment and Option Agreement with CWE European Holdings Inc., a leading CBD hemp retailer in Germany operating under the brand to acquire up to 100% of CWE through a multi-stage transaction. The transaction is expected to expand Neural's commercial footprint in Europe while maintaining its core commitment to drug discovery and mental health innovation. For further inquiries, please contact: Neural Therapeutics Inc. Ian Campbell, CEO E: [email protected] T: +1 (647) 697-NURL (6875) Marc Lakmaaker E: [email protected] T: +1.647.289.6640 CAUTIONARY DISCLAIMER STATEMENT No securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of the contents of this news release. This news release contains forward-looking statements ('FLS') relating opening of new franchise locations by CWE (operating as the timing and scope of participation at Mary Jane Berlin 2025, the growth and performance of business, Neural's indirect exposure to such growth through its investment in CWE, and Neural's continued focus on ethnobotanical drug discovery. FLS may also include statements regarding potential synergies from the transaction between Neural and CWE, expected consumer reception of products and projections about European market demand for hemp and CBD-related goods. FLS are often identified by terms such as 'will', 'may', 'should', 'anticipate', 'expect', 'plan' and similar expressions. These statements are not statements of historical fact, but rather predictions about future events, which are inherently subject to risks and uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned should not to place undue reliance on any forward-looking information. Although management considers such information to be reasonable at the time of preparation, may prove to be incorrect and actual outcomes may differ significantly. FLS contained in this news release are expressly qualified by this cautionary statement. The Company expressly disclaims any intention or obligation to update or revise such statements. A description of additional risk factors that may cause actual results to differ materially from FLS in Neural's disclosure documents posted The securities of Neural have not been registered under the U.S. Securities Act of 1933, as amended (the 'U.S. Securities Act'), or applicable state securities laws. The securities may not be offered or sold to, or for the account or benefit of, persons in the United States or 'U.S. Persons' (as defined in Regulation S under the U.S. Securities Act), unless registered or exempt from registration under the U.S. Securities Act and applicable state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy Neural's securities in the United States or any other jurisdiction where such an offer or sale would be FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. To view the source version of this press release, please visit
Yahoo
15 hours ago
- Yahoo
Why Curaleaf Stock Blasted Almost 5% Higher Today
A state previously very resistant to marijuana law reform is having something of a rethink. North Carolina's governor is re-evaluating the state's approach to weed. 10 stocks we like better than Curaleaf › With the mighty struggles the cannabis industry is currently experiencing, any positive news item concerning the sector is encouraging for investors. That was the dynamic behind the nearly 5% surge in Curaleaf (OTC: CURLF) stock on Wednesday, as yet another small step toward legalization was reported. That sub-5% pop was more than high enough to beat the flat-lining S&P 500 index. That news came from one of the dwindling number of U.S. states that has not yet legalized cannabis -- North Carolina. In a TV interview with WRAL News, the state's governor Josh Stein clearly expressed support for flipping the switch on legal weed. "If you are an adult and that's the choice you want to make, you should be able to make that choice," he said. So far, that doesn't seem to be just empty rhetoric. Stein has issued an executive order (EO) creating a North Carolina Advisory Council on Cannabis, a body that will evaluate the pros and cons of marijuana law reform in the state. It will be composed of as many as 30 individuals and include legislators, representatives from tribal groups, and agriculture specialists. In the interview, Stein expressed concern that the market for products associated with cannabis and hemp is unregulated and as such poses a risk to the state's youth. The situation will likely be one of the many explored by the council. Of course, this development in and of itself doesn't move the needle much for any pot company, let alone Curaleaf. Yet it's still another sign that the ice freezing U.S. marijuana law is melting, if only slowly and gradually. Investors are justified in feeling a small jolt of optimism and for hoping the momentum continues. Before you buy stock in Curaleaf, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Curaleaf wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Curaleaf Stock Blasted Almost 5% Higher Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
a day ago
- CBS News
Dozens of cannabis businesses get green light to open following Minnesota lottery
Dozens of lucky cannabis industry hopefuls got a big boost Thursday to open their business, two years after Minnesota legalized marijuana for recreational use. 'IT WAS EXHAUSTING' - Two years after recreational cannabis was legalized, lucky entrepreneurs can take a big step... Posted by WCCO & CBS News Minnesota on Thursday, June 5, 2025 The Office of Cannabis Management held a lottery for some of the license types with limited quantities under state law, including for retailers and cultivators. Applicants were pre-screened to join the lottery by the new state agency tasked with oversight of the new industry, and 249 were selected. Three times as many were eligible for the drawing. Eric Taubel, interim director of OCM, said those chosen will not officially get the license until they check off additional boxes, like passing a criminal background check, entering a labor peace agreement, negotiating with local governments for brick and mortar space and clearing an inspection. Still, the lotteries marked a significant step forward for a market that has not yet launched although it has been legal to smoke cannabis and grow plants at home since 2023. "We know that as soon as we finish this lottery, many of these applicants will start the hard work of getting ready to open those cannabis stores and building the cannabis market," Taubel told reporters ahead of the lottery Thursday morning. "Those applicants that win will receive information from the office next week about what their next steps are and what they need to do to accomplish it." But Taubel tempered expectations about the timeline for Minnesota to see a well-established marketplace because Minnesota's approach focused more on a craft industry with smaller businesses. So even with compacts with Tribal Nations that can already grow and sell cannabis on their reservations, supply will not initially keep up with demand and that it will also take time to scale. Growing and manufacturing can take several months. Some other license types, like wholesalers and testing facilities were not capped under state law, so a lottery was not necessary. They already found out if they received the greenlight to move forward. "The reality is that as we launch the first licenses in the coming weeks, we'll start to see new stores, new cultivators and new manufacturers shortly, but because of that deficit, it will take a while until the market reaches full maturity," he said. Nick Rahn, owner of the Warrior's Garden, a hemp-derived edibles store in St. Paul, said the long road to get to Thursday's lottery was exhausting and frustrating. But when his number was called out on the livestream, he cried tears of joy. "I don't see why it should have taken this long," he said, noting other states that have had retail sales sooner. "But today's the first step towards getting cannabis on shelves and I'm just excited. He needs to renovate his existing store to comply with regulations, among other additional steps, in order to re-open as an adult-use cannabis dispensary. But his target date is August 1 and he recognizes the supply chain challenges. "We're all kind of wondering the same thing: where are we going to get our product?" Rahn said.
